CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.40
Delayed Data
As of May 22
 -0.0138 / -0.98%
Today’s Change
1.07
Today|||52-Week Range
2.09
+5.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.9M669.3K0.0023.7K
 
 
 
 
Cost of Goods Sold----0.007.5K
 
 
Depreciation And Amortization38.1K20.5K17.4K48.2K
 
 
 
 
 
 
Operating ExpensesGross Income-----17.4K-31.9K
 
 
 
General Expenses6.5M5.2M5.7M6.5M
 
 
 
 
 
Research And Development3.5M2.4M2.7M2.8M
 
 
 
 
 
Total Operating Expenses6.5M5.2M5.7M6.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-4.5M-5.7M-6.5M
 
 
 
 
 
Extraordinary Credit0.000.000.0011.8K
 
 
Extraordinary Charge0.000.000.00-19.7M
 
 
Interest Expense On Debt0.0010.0M0.0028.1K
 
 
 
Other Expenses9.5K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-14.5M-5.7M-26.2M
 
 
 
 
 
Preferred Dividend-1.0M-335.0K0.000.00
 
 
 
Net Income-4.6M-14.5M-5.7M-26.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.8M19.1M26.1M28.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.8M19.1M26.1M28.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.78-$0.22-$0.92
 
 
 
 
 
EPS Diluted-$0.47-$0.78-$0.22-$0.92
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account